Manulife (Manufacturers Life Insurance)
DNA icon

Manulife (Manufacturers Life Insurance)’s Ginkgo Bioworks DNA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$105K Sell
17,210
-1,479
-8% -$12.3K ﹤0.01% 2615
2025
Q4 		$154K Sell
18,689
-314
-2% -$3.38K ﹤0.01% 2614
2025
Q3 		$277K Sell
19,003
-1,113
-6% -$13.3K ﹤0.01% 2425
2025
Q2 		$226K Buy
+20,116
New +$156K ﹤0.01% 2500
2024
Q3 		– Sell
-11,007
Closed -$147K – 3010
2024
Q2 		$147K Sell
11,007
-981
-8% -$29.3K ﹤0.01% 2711
2024
Q1 		$556K Buy
11,988
+979
+9% +$50.7K ﹤0.01% 2165
2023
Q4 		$744K Buy
11,009
+101
+0.9% +$6.18K ﹤0.01% 1974
2023
Q3 		$790K Buy
10,908
+3,977
+57% +$318K ﹤0.01% 1870
2023
Q2 		$516K Buy
6,931
+15
+0.2% +$888 ﹤0.01% 2019
2023
Q1 		$368K Buy
6,916
+175
+3% +$11.1K ﹤0.01% 2199
2022
Q4 		$451K Buy
6,741
+21
+0.3% +$1.93K ﹤0.01% 2059
2022
Q3 		$841K Sell
6,720
-37
-0.5% -$4.41K ﹤0.01% 1684
2022
Q2 		$671K Sell
6,757
-33
-0.5% -$4.03K ﹤0.01% 1850
2022
Q1 		$1.14M Buy
6,790
+5,932
+691% +$1.15M ﹤0.01% 1693
2021
Q4 		$305 Buy
+858
New +$408K ﹤0.01% 2595

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s DNA Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Ginkgo Bioworks (DNA) stake by 7.9% in Q1 2026, selling an estimated $12.3K and leaving 17,210 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Manulife (Manufacturers Life Insurance) first reported a position in DNA in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.14M in Q1 2022. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 17,210 shares of Ginkgo Bioworks worth $105K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,479 Ginkgo Bioworks shares in Q1 2026, an estimated $12.3K.
  • Ginkgo Bioworks made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2615 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 15 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Ginkgo Bioworks position peaked at $1.14M in Q1 2022.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.